| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 677,800 | 667,400 | 645,225 | 640,691 | | Cost of Revenue | 393,100 | 388,700 | 376,167 | 386,655 | | | Gross Profit | 284,700 | 278,700 | 269,058 | 254,036 | | | Operating Expenses | | Research Development | 42,600 | 42,300 | 47,569 | 45,322 | | Selling General and Administrative | 128,300 | 134,600 | 111,231 | 101,269 | | Non Recurring | 200 | (1,500) | 8 | 303 | | Others | 22,100 | 21,800 | 20,121 | 20,200 | | | | Total Operating Expenses | 193,200 | 197,200 | 178,929 | 167,094 | | | | Operating Income or Loss | 91,500 | 81,500 | 90,129 | 86,942 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,700 | 3,200 | 3,938 | 14,099 | | Earnings Before Interest And Taxes | 95,200 | 84,700 | 94,067 | 101,041 | | Interest Expense | 4,600 | 4,700 | 7,452 | 7,005 | | Income Before Tax | 90,600 | 80,000 | 86,615 | 94,036 | | Income Tax Expense | 37,600 | 30,900 | 30,229 | 22,975 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 53,000 | 49,100 | 56,386 | 71,061 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 53,000 | 49,100 | 56,386 | 71,061 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $53,000 | $49,100 | $56,386 | $71,061 |
|
0.17% Nasdaq 
Income Statement
